Page last updated: 2024-09-03

exp7711 and eprosartan

exp7711 has been researched along with eprosartan in 3 studies

Compound Research Comparison

Studies (exp7711)	Trials (exp7711)	Recent Studies (post-2010) (exp7711)	Studies (eprosartan)	Trials (eprosartan)	Recent Studies (post-2010) (eprosartan)
18	0	1	297	83	49

Protein Interaction Comparison

Protein	Taxonomy	eprosartan (IC50)
ATP-binding cassette sub-family C member 3	Homo sapiens (human)	6.65
Type-1A angiotensin II receptor	Rattus norvegicus (Norway rat)	0.1244
Type-1B angiotensin II receptor	Rattus norvegicus (Norway rat)	0.1244
Type-2 angiotensin II receptor	Rattus norvegicus (Norway rat)	0.1217

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Goldberg, MR; Greenlee, WJ; Irvin, JD; Prendergast, K; Smith, RD; Timmermans, PB; Wexler, RR	1
Berellini, G; Cruciani, G; Mannhold, R	1
Krovat, EM; Langer, T	1

Reviews

1 review(s) available for exp7711 and eprosartan

Article	Year
Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy. Journal of medicinal chemistry, 1996, Feb-02, Volume: 39, Issue:3 Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Humans; Receptors, Angiotensin; Structure-Activity Relationship	1996

Other Studies

2 other study(ies) available for exp7711 and eprosartan

Article	Year
Pharmacophore, drug metabolism, and pharmacokinetics models on non-peptide AT1, AT2, and AT1/AT2 angiotensin II receptor antagonists. Journal of medicinal chemistry, 2005, Jun-30, Volume: 48, Issue:13 Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Binding Sites; Biphenyl Compounds; Kinetics; Losartan; Models, Molecular; Molecular Conformation; Oxidation-Reduction; Pharmaceutical Preparations; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Structure-Activity Relationship; Tetrazoles	2005
Non-peptide angiotensin II receptor antagonists: chemical feature based pharmacophore identification. Journal of medicinal chemistry, 2003, Feb-27, Volume: 46, Issue:5 Topics: Acrylates; Algorithms; Angiotensin II; Biphenyl Compounds; Databases, Factual; Imidazoles; Lactones; Losartan; Models, Molecular; Molecular Conformation; Pyridines; Quantitative Structure-Activity Relationship; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Sulfones; Tetrazoles; Thiophenes	2003

Article

Year

Pharmacophore, drug metabolism, and pharmacokinetics models on non-peptide AT1, AT2, and AT1/AT2 angiotensin II receptor antagonists.

Journal of medicinal chemistry, 2005, Jun-30, Volume: 48, Issue:13

Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Binding Sites; Biphenyl Compounds; Kinetics; Losartan; Models, Molecular; Molecular Conformation; Oxidation-Reduction; Pharmaceutical Preparations; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Structure-Activity Relationship; Tetrazoles

2005

Non-peptide angiotensin II receptor antagonists: chemical feature based pharmacophore identification.

Journal of medicinal chemistry, 2003, Feb-27, Volume: 46, Issue:5

Topics: Acrylates; Algorithms; Angiotensin II; Biphenyl Compounds; Databases, Factual; Imidazoles; Lactones; Losartan; Models, Molecular; Molecular Conformation; Pyridines; Quantitative Structure-Activity Relationship; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Sulfones; Tetrazoles; Thiophenes

2003